Sam W. Lee
9Patents
2h-index
8Co-inventors
44Inventor score
Filing activity: Feb 28, 1991 → Aug 29, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5688641A | Cancer diagnosis using nucleic acid hybridization | Emerging Cross-Sectional Technologies | 5 | Expired |
| US8232318B2 | Approaches to treat cancer using HB-EGF inhibitors | Human Necessities | 2 | Active |
| US8318737B2 | Compounds and compositions for treating cancer | Chemistry; Metallurgy | 2 | Active |
| US5262528A | cDNA probe differentiating normal and cancer tissues | Chemistry; Metallurgy | 1 | Expired |
| US9458462B2 | Agents and methods for treating and preventing seborrheic keratosis | Physics | 0 | Active |
| US9658210B2 | Agents and methods for treating and preventing seborrheic keratosis | Physics | 0 | Active |
| US10822586B2 | Agents and methods for treating and preventing seborrheic keratosis | Physics | 0 | Active |
| US9469606B2 | Wnt/b-catenin inhibitors and methods of use | Chemistry; Metallurgy | 0 | Active |
| US10443038B2 | Agents and methods for treating and preventing seborrheic keratosis | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.